38 results about "Secondary prevention" patented technology

A complete nutritional composition comprising Lactococcus strains or probiotic is provided for reducing the symptoms of allergies in different groups of patients such as allergies originating from food allergens in young children or infants and respiratory allergens in children, adults and household pets. Preferably the composition reduces symptoms of allergies (secondary prevention) while not significantly affecting sensitization (primary prevention). The composition comprises a probiotic of the genus Lactococcus.

The present invention relates to a compound medicine for preventing and curing angiocardiopathy and cerebrovascular disease, belonging to the field of chemical medicine. It is characterized by that said compound medicine includes sexual hormones medicine, lipid-reducing medicine, hypotenser, hypoglycemic medicine and anticoagulant medicine. Said compound medicine can be made into various dosage forms. Besides, said compound medicine also can be used for curing the diseases of climacteric syndrome, osteoporosis, endometrial carcinoma, diabetes and metabolic syndrome, etc.

A compound medicine for preventing and treating the cardiovascular and cerebrovascular diseases of climacteric woman and adult man, climacteric syndrome, osteoporosis, endometrial carcinoma, senile dementia, diabetes and metabolism syndrome contains sexual hormones, hypolipemic component, antihypertensive component and anticoagulating component. It features that the ratio of its components is adjustable according to actual disease.

Provided is the use of a Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease, and particularly the use of the Salvia Miltiorrhiza composition in preparing drugs for secondary prevention of stable angina type coronary heart disease and the reduction of serious vascular events.

A complete nutritional composition comprising Bifidobacterium strains or probiotic is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition reduces symptoms of allergies (secondary prevention) and also reduces sensitization (primary prevention). The composition comprises a probiotic of the genus Bifidobacterium.

The invention relates to compounds of the formula I

as defined herein, which are inhibitors of activated thrombin-activatable fibrinolysis inhibitor. The compounds of the formula I are suitable for manufacturing medicaments for the prophylaxis, secondary prevention and therapy of one or more disorders which are associated with thromboses, embolisms, hypercoagulability or fibrotic changes.

The invention discloses a water source safety prevention and control device for a floating nuclear power plant, and relates to the technical field of water source safety of offshore floating devices.The device comprises a primary prevention and control component positioned at the periphery of the floating nuclear power plant and a secondary prevention and control component positioned at the periphery of a water intake port of a water tank of the floating nuclear power plant, wherein the primary prevention and control component comprises a plurality of pedestal tower frames which are arrangedat the periphery of the floating nuclear power plant and are connected to form a closed graph, and trash holding screens are arranged on the adjacent pedestal tower frames; the secondary prevention and control component comprises a cathode filter screen and an anode filter screen, and the water intake port of the water tank of the floating nuclear power plant is positioned in an inner filter screen; the secondary prevention and control component further comprises a direct current power supply; the anode of the direct current power supply is electrically connected with the anode on the conductive side of the anode filter screen; and the cathode of the direct current power supply is electrically connected with the cathode on the conductive side of the cathode filter screen. The device can effectively prevent and control the damage to the floating nuclear power plant caused by the aggregation and explosion of marine organisms, and filter and drive off impurities at the water intake port of the floating nuclear power plant in time.

The invention relates to an eye acupuncture eye patch for treating stroke disease which is characterized by being formed by an eye acupuncture eye patch, a thumbtack needle, a bondable eye patch witheye acupuncture acupoint holes and a medicine bag, wherein eye acupuncture acupoint partition indicator diagrams on the surface of the eye acupuncture eye patch are arranged on positions, corresponding to the two eyes, of the surface of the eye acupuncture eye patch; each eye acupuncture acupoint partition indicator diagram is provided with a hepatic region, an upper jiao region, a renal region, alower jiao region, an opticoel partition line and a quadrangle directrix corresponding to the peripheral directions of the two eyes; and an operable part is formed by the thumbtack needle, the bondable eye patch with eye acupuncture acupoint holes and the medicine bag. According to the invention, the bondable eye patch with eye acupuncture acupoint holes and the thumbtack needle are used for replacing eye acupuncture in the rehabilitation process, and the eye acupoint region is acupunctured so as to stimulate corresponding viscera channel qi, enhance the rehabilitation curative effect, and promote the limb function recovery. In a non-rehabilitation period, treatment can be continued by stimulation with needle at the eye acupoint region. By wearing the protective eye patch at night, treatment continuity can be ensured, and secondary prevention of cerebrovascular disease is facilitated.

The invention discloses an intrauterine surgical procedure which comprises the steps of preoperative preparation, anaesthesia, operation and postoperative management. The intrauterine surgical procedure is applied to clinical treatment gradually, can rectify certain congenital monstrosity in early course as well as in an intrauterine period when the operative effect is best and can avoid certain irreversible intrauterine damage so as to achieve permanent curative effect. Adopting the intrauterine surgical procedure of the invention can greatly lower disability rate, mitigate the permanent undesirable impact on society and family after an oaf is born, provide chances to correct certain congenital deformities, in particular to serious or lethal deformities for human, play a great role in promoting population quality and facilitating secondary prevention and reduce birth defect to the largest extend.

The invention relates to a method for identification of an individual at increased risk of thrombosis or an atherothrombotic event, or a major bleeding event, comprising a step of assaying a biological sample from the individual for the presence of a SNP in the PPARGC1β, CNTN4, LZTS1 and KCNE4 genes, wherein the presence of a SNP in the PPARGC1β, CNTN4, LZTS1 and KCNE4 genes correlates with the individual being at increased risk of thrombosis or an atherothrombotic event, or a major bleeding event. Typically, the SNP is selected from the SNPs provided in Tables 1 and 2. The invention also provides a method of identifying an individual most likely to gain benefit from single anti-platelet therapy in the primary prevention of cardiovascular events, a method of identifying an individual most likely to gain benefit from dual anti-platelet therapy in the secondary prevention of cardiovascular events, and a method of identifying an individual likely to suffer a significant bleeding complication when undergoing treatment with drugs which influence haemostasis.

The invention discloses a traditional Chinese medicine composition for improving immunity, reducing blood fat and protecting the heart and brain. The traditional Chinese medicine composition is prepared from radix astragali, radix salviae miltiorrhizae, radix notoginseng, folium ginkgo, radix puerariae, emblic leafflower fruits and radix polygonati officinalis; through simultaneous action by adopting two ways, i.e., a four-way theory and Qi tonifying and blood stasis removing (strengthening immunity and reducing blood fat), the traditional Chinese medicine composition has a relatively good treatment and health-care action on cardiovascular and cerebrovascular diseases such as hyperlipidemia, low-density lipoproteincholesterol (HDL-C), cardiac muscle ischemia, cerebral ischemia, immunity hypofunction and other symptoms such as insomnia, asthenia, anorexia, stomachache and hypertension, the effect of supplementing good without evil is achieved, and the traditional Chinese medicine composition can be applied to the secondary prevention of the cardiovascular and cerebrovascular diseases.

A method for secondary cardiovascular prevention in a patient includes formulating a single dosage unit containing a beta-adrenergic blocking agent and a cholesterol-lowering agent that is a statin where the single dosage unit contains a quantity of medications sufficient for secondary prevention of a heart attack in the patient, and administering the single dosage unit to the patient for secondary prevention of a heart attack. The method further includes the secondary prevention of a heart attack in a non-hypertensive patient.